Save your place

Sign in to WhoBought

Please try again later.

Autolus Therapeutics plc (AUTL) institutional ownership

Latest close $1.49 Jul 31, 2026
Market cap$367M 52-week range SectorHealthcare
Funds holding · Q1 2026
72
reported AUTL position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
32 buyers · 40 sellers

Autolus Therapeutics plc (AUTL) price and institutional activity

Dates

Q1 2026

$0 bought by 32 investors
Mak Capital One LLCBalyasny Asset Management L.P. +30 more
$0 sold by 40 investors
BlackRockAcadian Asset Management LLC +38 more
Bought Sold Totals per quarter; hover a bar for the names.

Autolus Therapeutics plc (AUTL) institutional activity · 40

Investor Type Est. change Change Δ Own Date
BlackRock · Reduced
Change −2.2M Date Q1 2026
BlackRock Reduced· Q1 2026 −2.2M Q1 2026
Acadian Asset Management LLC · Reduced
Change −1.8M Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −1.8M Q1 2026
Armistice Capital, LLC · Reduced
Change −1.7M Date Q1 2026
Armistice Capital, LLC Reduced· Q1 2026 −1.7M Q1 2026
Atle Fund Management AB · Exited
Change −1.2M Δ Own −100.0% Date Q1 2026
Atle Fund Management AB Exited· Q1 2026 −1.2M −100.0% Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −806K −26.0% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −700K −60.4% Q1 2026
Morgan Stanley · Reduced
Change −455K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −455K Q1 2026
Jane Street Group, LLC · Reduced
Change −435K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −435K Q1 2026
Marshall Wace, LLP · Reduced
Change −244K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −244K Q1 2026
Tudor Investment Corp Et Al · Reduced
Change −236K Date Q1 2026
Tudor Investment Corp Et Al Reduced· Q1 2026 −236K Q1 2026
Susquehanna International Group, LLP · Reduced
Change −200K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −200K Q1 2026
Frazier Life Sciences Management, L.P. · Reduced
Change −175K Date Q1 2026
Frazier Life Sciences Management, L.P. Reduced· Q1 2026 −175K Q1 2026
Gsa Capital Partners LLP · Exited
Change −120K Δ Own −100.0% Date Q1 2026
Gsa Capital Partners LLP Exited· Q1 2026 −120K −100.0% Q1 2026
Bank of America Corp · Reduced
Change −116K Date Q1 2026
Bank of America Corp Reduced· Q1 2026 −116K Q1 2026
Aubrey Capital Management Ltd · Reduced
Change −95K Date Q1 2026
Aubrey Capital Management Ltd Reduced· Q1 2026 −95K Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 40

Famous investor activity in Autolus Therapeutics plc (AUTL)

Autolus Therapeutics plc (AUTL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Young William D. · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Young William D. Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Rao Madduri Ravin · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Rao Madduri Ravin Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Richardson Ryan · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Richardson Ryan Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Leiderman Elisabeth · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Leiderman Elisabeth Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Iannone Robert · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Iannone Robert Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Butitta Cynthia M. · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Butitta Cynthia M. Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Bain Linda · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Bain Linda Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Azelby Robert · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Azelby Robert Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
Bonney Michael W. · Director 2 operations 79K
Owned 48K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Bonney Michael W. Director 2 operations 79K 48K Jun 29, 2026 Jul 1, 2026
9 of 9

Autolus Therapeutics plc (AUTL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ppf Biotech B.V. 14.6M
% of shares outstanding 16.1% Filing date Oct 5, 2022
Ppf Biotech B.V. 14.6M 16.1% Oct 5, 2022
Mak Capital Fund LP 33.6M
% of shares outstanding 12.6% Filing date May 15, 2026
Mak Capital Fund LP 33.6M 12.6% May 15, 2026
Biontech SE 33.3M
% of shares outstanding 12.5% Filing date Feb 21, 2024
Biontech SE 33.3M 12.5% Feb 21, 2024
Syncona Portfolio Ltd 30.7M
% of shares outstanding 11.6% Filing date Nov 14, 2024
Syncona Portfolio Ltd 30.7M 11.6% Nov 14, 2024
Syncona Portfolio Ltd 28.8M
% of shares outstanding 10.8% Filing date May 7, 2025
Syncona Portfolio Ltd 28.8M 10.8% May 7, 2025
Wellington Management Group LLP 24.2M
% of shares outstanding 9.1% Filing date Nov 8, 2024
Wellington Management Group LLP 24.2M 9.1% Nov 8, 2024
Qatar Investment Authority 15.0M
% of shares outstanding 9.0% Filing date Dec 13, 2022
Qatar Investment Authority 15.0M 9.0% Dec 13, 2022
Blackstone Inc. 23.8M
% of shares outstanding 8.8% Filing date May 21, 2024
Blackstone Inc. 23.8M 8.8% May 21, 2024
8 of 25

Autolus Therapeutics plc (AUTL) ownership FAQ

Who owns AUTL?

72 reporting institutions disclosed AUTL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.